AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
BOSTON, May 6, 2013 /PRNewswire/ -- AG Mednet  today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance software, MDHVC is strengthening its commitment to quality in multi-center and multi-national cardiovascular trials by immediately detecting image submission errors that slow down the clinical trial process and add unnecessary costs for sponsors.
As one of the top cardiovascular hospitals in the United States, MDHVC provides effective, efficient, and compassionate cardiovascular care through research in cardiology and cardiovascular surgery, education and a full continuum of patient care.
"Our mission is to serve as the premier international benchmark for cardiology and cardiovascular surgery and clinical trials," said Dr. Sherif Nagueh, director of the MDHVC echocardiography core laboratory. "AG Mednet brings a powerful technology component to our clinical trial work, letting us spend more time examining the images that impact patient outcomes, and less time correcting submission errors that delay forward progress."
According to industry research, more than half of all image-related clinical trial query stoppages result from preventable human errors that can delay a trial for up to seven weeks. The AG Mednet Submission Quality & Compliance  module immediately detects errors that result in query stoppages and gives ICLs a system to verify information, automatically update support systems including EDC (electronic data capture), and dramatically reduce the amount of queries returned for correction or re-scanning.
In clinical trials conducted using AG Mednet technology, sponsors experience a more than 75% query reduction rate, resulting in significant cost savings and faster decision times.
"Cardiovascular clinical trials are very image-intensive and require extreme precision and expertise," said Abraham Gutman , president and CEO of AG Mednet. "The MDHVC team led by Dr. Nagueh is once again advancing the cardiovascular clinical trial industry by adopting technology that removes unnecessary administrative work and creates more time for patient care."
For more information about AG Mednet and how the new AG Mednet module  delivers benefits and quality assurance to imaging trial sponsors, imaging core labs, clinical research organizations and principal investigators in a way not possible until today, please visit www.agmednet.com/zerodelay .